AstraZeneca Plc on Thursday signed a deal with a China-based company for producing its potential drug to treat novel coronavirus in mainland China. Shenzhen Kangtai Biological Products becomes the first Chinese company to enter into a deal with AstraZeneca.

AstraZeneca signs first deal with Chinese firm to produce COVID-19 vaccine

UK on Thursday accused Russian hackers of trying to steal research on potential coronavirus vaccines. Also Read: COVID-19 vaccine - Oxford university's phase one human trials shows encouraging trends Britain's National Cyber Security Centre said a Russian group linked to the country's intelligence services called APT29 has also attacked US and Canadian vaccine research organizations.

Group linked to Russian intelligence hacking COVID-19 vaccine research: UK

oxford-university-vaccine

Oxford University Vaccine, News on Oxford University Vaccine, stories on Oxford University Vaccine, articles on Oxford University Vaccine, Oxford University Vaccine stories at Wion, Oxford University Vaccine news, Oxford University Vaccine latest news

oxford university-vaccine

AstraZeneca signs first deal with Chinese firm to produce COVID-19 vaccine

Group linked to Russian intelligence hacking COVID-19 vaccine research: UK